Literature DB >> 32063793

Erythrodermic psoriasis secondary to systemic corticosteroids.

Matthew Heinrich1, Elizabeth Cook1, Jenna Roach2, Rita Medrano Juarez3, Drew Payne3, Randy Atkins2, Cloyce Stetson2.   

Abstract

Erythroderma is an uncommon, potentially life-threatening condition, which has many causes, including uncontrolled psoriasis. We present a 58-year-old woman with psoriasis who, after an abrupt discontinuation of systemic corticosteroids, developed erythrodermic psoriasis with extensive body surface involvement requiring hospital admission. Erythrodermic psoriasis requires a high index of suspicion to diagnose it in a timely fashion and treat it to prevent complications.
Copyright © 2020 Baylor University Medical Center.

Entities:  

Keywords:  Erythroderma; erythrodermic psoriasis; psoriasis; systemic corticosteroids; topicals

Year:  2019        PMID: 32063793      PMCID: PMC6988617          DOI: 10.1080/08998280.2019.1686911

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

Review 1.  Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.

Authors:  Arielle R Nagler; Sara Samimi; Andras Schaffer; Carmela C Vittorio; Ellen J Kim; Alain H Rook
Journal:  J Am Acad Dermatol       Date:  2011-10-17       Impact factor: 11.527

2.  U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.

Authors:  D Creamer; S A Walsh; P Dziewulski; L S Exton; H Y Lee; J K G Dart; J Setterfield; C B Bunker; M R Ardern-Jones; K M T Watson; G A E Wong; M Philippidou; A Vercueil; R V Martin; G Williams; M Shah; D Brown; P Williams; M F Mohd Mustapa; C H Smith
Journal:  Br J Dermatol       Date:  2016-06       Impact factor: 9.302

Review 3.  Pityriasis rubra pilaris: a review of diagnosis and treatment.

Authors:  Annette Klein; Michael Landthaler; Sigrid Karrer
Journal:  Am J Clin Dermatol       Date:  2010       Impact factor: 7.403

4.  Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.

Authors:  Misha Rosenbach; Sylvia Hsu; Neil J Korman; Mark G Lebwohl; Melodie Young; Bruce F Bebo; Abby S Van Voorhees
Journal:  J Am Acad Dermatol       Date:  2009-08-08       Impact factor: 11.527

5.  Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients.

Authors:  A S Boyd; A Menter
Journal:  J Am Acad Dermatol       Date:  1989-11       Impact factor: 11.527

Review 6.  A review of the diagnosis and management of erythroderma (generalized red skin).

Authors:  Nisha Mistry; Ambika Gupta; Afsaneh Alavi; R Gary Sibbald
Journal:  Adv Skin Wound Care       Date:  2015-05       Impact factor: 2.347

7.  Erythrodermic Psoriasis in a Man with Monoclonal B-cell Lymphocytosis.

Authors:  Stella X Chen; Brian R Hinds; Aaron M Goodman; Philip R Cohen
Journal:  Cureus       Date:  2017-12-11

8.  Wet wrap dressings as a rescue therapy option for erythrodermic psoriasis.

Authors:  Beatriz Regina de Fatima Navrotski; Francielle Melina Nihi; Michael Joseph Camilleri; Felipe Bochnia Cerci
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

9.  Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Authors:  Rasnik K Singh; Kristina M Lee; Derya Ucmak; Merrick Brodsky; Zaza Atanelov; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2016-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.